Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group (11,963)
09/2005
09/29/2005US20050215794 Group IB compounds used as condensation, amination, amidation or arylation catalysts; catalysis; efficiency; forming a carbon-carbon bond between a reactant comprising a nucleophilic carbon atom, e.g., enolate or malonate anion, and activated carbon of an aryl, heteroaryl, or vinyl halide or sulfonate
09/29/2005US20050215749 Low hydrolytic chlorine; curable, for a material in an electronics.
09/29/2005US20050215594 Diabetes, obesity, urogenital disorders, cardiovascular disorders, atherosclerosis; 4-[(2R)-2-(([(2R)-2-(3-chlorophenyl)-2-hydroxyethyl]amino)methyl)-3,4-dihydro-2H-chromen-6-yl]benzoic acid for example
09/29/2005DE102004012068A1 Neue alkyl-haltige 5-Acylindolinone, deren Herstellung und deren Verwendung als Arzneimittel New alkyl-containing 5-Acylindolinone, their preparation and their use as medicaments
09/29/2005CA2559207A1 Salvinorin derivatives and uses thereof
09/29/2005CA2558652A1 Opioid receptor antagonists
09/28/2005EP1580278A1 Process for producing macrolide compound
09/28/2005CN1675220A Epothilone derivatives
09/28/2005CN1674895A Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals
09/28/2005CN1220490C Use of piperazine oxirane derivatives in preparation of medicine for inducing death of neoplastic cells
09/27/2005US6949583 Aminoalkoxybenzoyl-benzofuran or benzothiophene derivatives, method of preparing same and compositions containing same
09/27/2005US6949569 Dual molecules containing a peroxide derivative, synthesis and therapeutic applications thereof
09/27/2005US6949545 Tissue remodeling; antiinflammatory agents; autoimmune disease
09/27/2005US6949537 LY294002 and analogs thereof comprising a reversibly quaternized amine; use of the pro-compounds for treatment of a condition associated with PI-3 kinase activity, including inflammatory disease, age-related macular degeneration, hypertension
09/27/2005CA2245680C Method of detection of influenza virus and compounds for use therein
09/22/2005WO2005087727A1 Novel alkyl-containing 5-acylindolinones, their preparation and their use as pharmaceutical products
09/22/2005WO2005087222A1 C7 lactyloxy-substituted taxanes
09/22/2005WO2005087215A1 Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors
09/22/2005WO2005054809A3 Irciniastatins a and b
09/22/2005US20050209311 C7 lactyloxy-substituted taxanes
09/22/2005US20050209302 Glycogen synthase kinase (GSK-3) inhibitors; diabetes, neurodegenerative diseases, stroke, neurotraumatic injuries and bipolar disorders; 5-acetyl-3-[3-(methoxycarbonylpropylamino)-(benzo-[1.3]dioxyo-5-yl)-methylidene]-2-indolinone for example
09/22/2005US20050209278 Piperidinyl- and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors
09/22/2005CA2559139A1 Novel alkyl-containing 5-acylindolinones, their preparation and their use as pharmaceutical products
09/22/2005CA2558249A1 Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors
09/21/2005EP1577294A1 S-substituted n-1- (hetero)aryl alkyl-n - (hetero)aryl alkylysothiocarbamides, method for the production thereof, physiologically active s-substituted n-1- (hetero )aryl alkyl-n - (hetero)aryl alkylysothiocarbamides,a pharmaceutical compound and curing method
09/21/2005EP1299382B1 Composition and antiviral activity of substituted indoleoxoacetic piperazine derivatives
09/21/2005CN1671856A Novel physiologically active substances
09/21/2005CN1671700A Substituted alkylamine derivatives and methods of use
09/21/2005CN1671684A Novel benzodioxoles
09/21/2005CN1671373A Compounds useful for the inhibition of ALDH
09/21/2005CN1670217A Process for the preparation of pseudomonic acid A antibiotic by microbiological method
09/20/2005CA2127047C Preparation of astaxanthin, novel intermediates therefor and the preparation thereof
09/15/2005WO2005085275A1 Inhibitors of hepatitis c virus ns3 protease
09/15/2005WO2005085237A1 Fused heterocycle derivative, medicinal composition containing the same, and medicinal use thereof
09/15/2005WO2005085222A1 Liquid crystal compound comprising two condensed and substituted rings
09/15/2005WO2005084365A2 Triptolide lactone ring derivatives as immunomodulators and anticancer agents
09/15/2005WO2005039496A3 Inhibitors of cathepsin s
09/15/2005US20050203173 PI-3 kinase inhibitor prodrugs
09/15/2005US20050203145 Chronic inflammation, rheumatoid arthritis, colitis, asthma and psoriasis; solid phase synthetic methods to efficiently construct numerous drug-like libraries
09/15/2005US20050203124 Compounds for the sustained reduction of body weight
09/15/2005CA2557322A1 Inhibitors of hepatitis c virus ns3 protease
09/15/2005CA2557260A1 Triptolide lactone ring derivatives as immunomodulators and anticancer agents
09/14/2005EP1572239A1 Method of using a cox-2 inhibitor and a topoisomerase ii inhibitor as a combination therapy in the treatment of neoplasia
09/14/2005EP1499609A4 Pesticidal heterocycles
09/14/2005CN1668585A 3, 6-disubstituted azabicyclo [3.1.0]hexane derivatives useful as muscarinic receptor antagonists
09/14/2005CN1668287A Inhibition by 3-deoxyflavonoids of t-lymphocyte activation and therapies related thereto
09/13/2005US6943259 Halogenated triptolide derivatives as immunomodulators and anticancer agents
09/13/2005US6943182 Cyclopentabenzofuran derivatives and their use
09/13/2005CA2231105C Farnesyl protein transferase inhibiting (imidazol-5-yl)methyl-2-quinolinone derivatives
09/09/2005WO2005082856A2 Tetrahydroquinolinones and their use as antagonists of metabotropic glutamate receptors
09/09/2005WO2005082855A1 Novel pyridine derivative and pyrimidine derivative (2)
09/09/2005WO2005082854A1 Novel pyridine derivative and pyrimidine derivative (1)
09/09/2005CA2543861A1 Novel pyridine derivative and pyrimidine derivative (2)
09/09/2005CA2543859A1 Novel pyridine derivative and pyrimidine derivative (1)
09/08/2005US20050197361 Tetrahydroquinolinones and their use as antagonists of metabotropic glutamate receptors
09/07/2005EP1569928A1 Therapeutic compounds and methods
09/07/2005EP1189893B1 Substituted 2-aryl-1,2,4-triazine-3,5-di(thi)one
09/07/2005CN1665807A Novel physiolgically active substances
09/07/2005CN1665785A 2-cyano-4-fluoropyrrolidine derivative or its salt
09/07/2005CN1665502A MCHIR antagonists
09/06/2005US6939977 For improved binding of CB1/CB2 receptors; side effects reduction
09/06/2005US6939892 Compositions for treating or preventing malaria and method of treating malaria
09/06/2005US6939866 Antitumor agents; skin disorders; anticancer agents
09/01/2005WO2005079798A1 Pyrimidine derivatives and use thereof as agricultural and horticultural fungicides
09/01/2005WO2005079378A2 Synthetic techniques and intermediates for polyhydroxy dienyl lactones and mimics thereof
09/01/2005US20050192277 Histamine-3 receptor antagonists; 4-(2-{2-[(2R)-2-methyl-1-pyrrolidinyl]ethyl}-1-benzofuran-4-yl)benzonitrile; acute myocardial infarction, asthma, psychological disorders, gastrointestinal disorders, inflammation, jet lag, cancer, septic shock, Tourette's syndrome, neurodegenerative disorders
09/01/2005CA2556480A1 Pyrimidine derivatives and use thereof as agricultural and horticultural fungicides
08/2005
08/31/2005EP1568774A2 Recombinant production of novel polyketides
08/31/2005EP1567508A1 1,2,4-triazole derivative, method for preparing the same, and pharmaceutical composition containing the same
08/31/2005EP1478437B1 Acc inhibitors
08/31/2005EP1182200B1 Tricyclic fused heterocycle compounds, process for preparing the same and use thereof
08/31/2005CN1662526A Hydroxy pyranone derivative and preparation method thereof
08/31/2005CN1662508A Compounds, compositions and methods
08/31/2005CN1662496A Cannabinoid receptor agonists
08/31/2005CN1660821A Oxodiethylenediamine derivative and light stabilized composition
08/31/2005CN1660815A Cyclic amine derivatives and their use as drugs
08/30/2005US6936613 for treatment of central nervous system diseases and disorders, which are responsive to modulation of the Gamma amminobutyric acid (GABA) receptor complex, and for inducing and maintaining anesthesia, sedation and muscle relaxation
08/25/2005WO2005077943A1 1 , 3 - dioxane derivatives and analogues thereof useful in the treatment of i.a. obesity and diabetes
08/25/2005WO2005077940A1 Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
08/25/2005US20050187275 Preterm labor, premature birth, dysmenorrhea, inappropriate secretion of vasopressin, congestive heart failure, arterial hypertension, liver cirrhosis, nephrotic syndrome and ocular hypertension; 3-(5-((3-chlorobenzyl)sulfanyl)-4-(3-methoxypropyl)-4H-1,2,4-triazol-3-yl)-N-(2-methoxybenzyl)propanamide
08/25/2005US20050187238 Benzofuran derivatives, their production and use
08/25/2005CA2555817A1 1 , 3 - dioxane derivatives and analogues thereof useful in the treatment of i.a. obesity and diabetes
08/25/2005CA2553630A1 Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
08/24/2005EP1565428A1 Substituted ureas and carbamates
08/24/2005CN1658724A Luminescent element material and luminescent element comprising the same
08/24/2005CN1216050C 5,6,7-trinor -4,8-inter-m-phenylene PGI2 derivative and drugs containing the same
08/24/2005CN1215835C Ketone derivatives and medical use thereof
08/23/2005US6933261 2,4,5-Trisubstituted phenylketoenols
08/18/2005WO2005075464A1 Pyridine derivatives as connabinoid receptor modulators
08/18/2005WO2005075458A1 Pyrimidine derivatives as orexin receptors antagonists
08/18/2005WO2005075451A1 Aminodibenzodioxin derivative and organic electroluminescent device using same
08/18/2005WO2005075435A1 Modulators of atp-binding cassette transporters
08/18/2005US20050182098 Administering taxanes having a carbamoyloxy substituent at C(10), a hydroxy substituent at C(7), and a range of C(2), C(9), C(14), and side chain substitutions for inhibiting tumor growth
08/18/2005DE102004005106A1 New furanone and bicyclooctane derivatives, e.g. sorbifuranone A, B or C, sorbivinetone and sorbivinetol, useful as antitumor agents, prepared e.g. by culturing Penicillium fungi
08/18/2005CA2555453A1 Cross-coupling process for production of aromatic compounds from aliphatic organic compounds and aromatic organometallic reagents
08/18/2005CA2554796A1 Modulators of atp-binding cassette transporters
08/17/2005EP1562928A1 Aromatic sulfone hydroxamic acids and their use as protease inhibitors
08/17/2005EP1562895A1 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
08/17/2005CN1215068C Prepn process of 2, 3, 3', 4'-diphenyl tetraformic dianhydride and its derivative
08/11/2005WO2005073223A1 Method of stabilizing macrolide compound
1 ... 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 ... 120